Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity
- PMID: 28940918
- DOI: 10.1002/hec.3570
Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity
Abstract
Understanding the role that drug adherence has on health outcomes in everyday clinical practice is central for the policy maker. This is particularly true when patients suffer from asymptomatic chronic conditions (e.g., hypertension, hypercholesterolaemia, and diabetes). By exploiting a unique longitudinal dataset at patient and physician level in Italy, we show that patients and physicians unobserved characteristics play an important role in determining health status, at least as important as drug adherence. Most importantly, we find that both adherence and prescribed treatment regimen effects are highly heterogeneous across physicians, highlighting their crucial role in shaping patients' health status.
Keywords: drug adherence; health outcomes; patient heterogeneity; physician heterogeneity.
Copyright © 2017 John Wiley & Sons, Ltd.
Similar articles
-
How can physicians improve medication adherence and outcomes in dermatological conditions?Expert Rev Pharmacoecon Outcomes Res. 2024 Sep;24(7):799-806. doi: 10.1080/14737167.2024.2370911. Epub 2024 Jun 24. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38914008 Review.
-
[A survey carried out among Italian physicians regarding non-required clinical examinations, treatments and procedures in the current clinical practice: results and considerations.].Recenti Prog Med. 2017 Jul-Aug;108(7):324-332. doi: 10.1701/2731.27838. Recenti Prog Med. 2017. PMID: 28845854 Italian.
-
Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study.Health Psychol. 1993 Mar;12(2):93-102. doi: 10.1037/0278-6133.12.2.93. Health Psychol. 1993. PMID: 8500445
-
Effects of physician-related factors on adult asthma care, health status, and quality of life.Am J Med. 2003 May;114(7):581-7. doi: 10.1016/s0002-9343(03)00053-6. Am J Med. 2003. PMID: 12753882
-
Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy.Eur J Clin Pharmacol. 2005 May;61(3):225-30. doi: 10.1007/s00228-005-0911-z. Epub 2005 Apr 12. Eur J Clin Pharmacol. 2005. PMID: 15824910
Cited by
-
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany.Int J Environ Res Public Health. 2020 Jun 9;17(11):4113. doi: 10.3390/ijerph17114113. Int J Environ Res Public Health. 2020. PMID: 32526943 Free PMC article.
-
Are patients more adherent to newer drugs?Health Care Manag Sci. 2020 Dec;23(4):605-618. doi: 10.1007/s10729-020-09513-5. Epub 2020 Aug 8. Health Care Manag Sci. 2020. PMID: 32770286 Free PMC article.
-
Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.J Econ Behav Organ. 2022 Dec;204:1-14. doi: 10.1016/j.jebo.2022.10.012. Epub 2022 Oct 14. J Econ Behav Organ. 2022. PMID: 36268162 Free PMC article.
-
Insurance barriers and inequalities in health care access: evidence from dual practice.Health Econ Rev. 2024 Mar 21;14(1):23. doi: 10.1186/s13561-024-00500-y. Health Econ Rev. 2024. PMID: 38512590 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources